-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
December 20, 2011 - Subgroup analyses for age, gender and co-morbidities will
be undertaken to assess clinical diversity … Grading the Evidence for Each Key Question
We will assess the overall strength of the evidence (SOE … For KQ1 and KQ2, we will assess SOE using the method for medical tests
29
and for
KQ6 we will use … We will assess applicability in accordance
with the Methods Guide for Medical Test Reviews.
29 … Evid Rep Technol Assess 2006;(142):1-147.
5. de Lemos JA, McGuire DK, Khera A, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-evidence-summary.pdf
June 01, 2021 - Studies varied by intervention, comparator, measures used to assess effects, and
reported detail. … Studies varied by intervention, comparator, measures used to assess effects, and reported
detail.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
July 01, 2023 - When assessing non-randomized studies, we will
7
use specific items in the ROBINS-I tool that assess … Evid Rep Technol Assess (Full Rep).
2013 Mar(211):1-945. PMID: 24423049.
21.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
July 27, 2023 - We will not independently assess original studies
included in any such systematic review. … When assessing non-randomized studies, we will use specific items in the ROBINS-I
tool that assess … We will not independently assess original studies included in any such systematic review.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hemorrhage-postpartum_research-protocol.pdf
June 11, 2014 - We will, however, re-assess non-English studies as we update our MEDLINE
search. … deem to be of low risk of bias and able to affect
conclusions
• For KQ 5, studies must explicitly assess … Assessment of Methodological Risk of Bias of Individual Studies
We will assess the quality of studies … We will use the McMaster Quality Assessment Scale of Harms (McHarm) tool to
assess harms studies.52 … Two senior investigators will
independently assess each included study.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-ems-protocol-amendment.pdf
January 28, 2019 - Impetus for the Review
This systematic review will assess the comparative effectiveness and harms … may contact authors of candidate articles for
clarification of reported study details in order to assess … non-randomized studies, we will
use the Newcastle Ottawa Scale.18
Two reviewers will independently assess … When quantitative pooling of studies is possible, we will assess for the presence of
statistical heterogeneity … To assess for the presence of publication bias, visual inspection of funnel plots will be
considered
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/clinical-care-protocol.pdf
January 01, 2024 - For this rapid review, we plan to focus on studies that assess the
effectiveness of interventional … .27 When
assessing non-randomized studies, we will use specific items in the ROBINS-I tool that
assess … Analysis of Subgroups or Subsets
We will assess whether the effectiveness of programs differs according
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research.pdf
February 01, 2014 - all Four
Outcomes, and Relative Weights of Outcomes
ix
Background
Systematic reviews often assess … We were unable to assess the strength of evidence
around the benefit and harm comparison metric, or … We were unable to assess competing
risk.
We presented results using excess
events. … There are no estimates of uncertainty
(such as 95% CI), but we could
assess the probability of the … In the absence of a gold standard method for elicitation of
preferences, such research should assess
-
effectivehealthcare.ahrq.gov/products/palliative-care-tools/technical-brief-2017
-
effectivehealthcare.ahrq.gov/products/palliative-care-tools/research-protocol
-
effectivehealthcare.ahrq.gov/products/chronic-cough/research
-
effectivehealthcare.ahrq.gov/products/chronic-cough/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
September 02, 2016 - For newly found studies, we will record additional data and assess their risk of bias. … For
studies identified in the original review, we will also assess the congruence of any
additional … If meta-analyses
are not conducted, we will assess whether the new studies fall within the range of … Evid Rep Technol Assess (Summ). 2004 Mar(94):1-8.
PMID: 15133888.
18. … Evid Rep Technol Assess (Summ). 2004 Mar(93):1-6. PMID: 15133887.
19.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/trauma-child-interventions_research-protocol.pdf
March 26, 2012 - To assess
the risk of bias of studies, we will use criteria described in the AHRQ Methods Guide
for … will use questions
specified in the RTI Item Bank36 and the Cochrane Risk of Bias tool.37 We will assess … To determine whether quantitative analyses are appropriate, we will
assess the clinical heterogeneity … Two reviewers will assess each domain for each
key outcome listed in the framework, and conflicts will … To assess the applicability of a body of evidence, we will consider
the consistency of results across
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
September 18, 2012 - can monitor the safety of clinical trial subjects and ensure that the study design is
appropriate to assess … Assessing Strength of Evidence: Grading the Strength of Evidence for Individual
Outcomes
We will assess … applicability in mind; furthermore, they sometimes report only a few of the factors needed
to fully assess … Evidence tables will clearly distinguish studies designed to
assess effectiveness versus those designed … specifically to assess safety.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-patient-family-engagement.pdf
July 01, 2023 - biases.14 When assessing non-randomized studies, we will
use specific items in the ROBINS-I tool that assess
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/thromboembolism-update_research-protocol.pdf
February 17, 2016 - February 17, 2016 9
Assessment of Methodological Risk of Bias of Individual Studies – We will assess … body of evidence as per the AHRQ methods guide on assessing
the strength of evidence.5 We plan to assess … AHRQ
approach, for each intervention and comparison of intervention, and for each outcome,
we will assess … Assessing Applicability: We will assess the applicability within and across studies with
reference to … At a minimum, factors of
interest to assess applicability will be the key potential modifiers listed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-sepsis.pdf
July 01, 2023 - .12 When
assessing non-randomized studies, we will use specific items in the ROBINS-I tool that
assess
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-protocol.pdf
June 05, 2024 - evolve and it will not be practical to evaluate each new generation of a test in
a large trial to assess … Objectives of the Review
This systematic review will assess the accuracy, effectiveness, and harms … In
some cases, we may report an outcome-specific ROB rating within a study if we assess the outcome … Two reviewers will independently assess the ROB for each study;
disagreements on domain-level ratings … For KQs 1 and 2, we will assess reporting bias
by comparing protocols to final reported methods and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
December 11, 2018 - the Department
of Health & Human Services (HHS) to contract with the Institute of Medicine (IOM) to
assess … We will assess strength of
evidence and draw conclusions based on the totality of evidence available … of Bias of Individual Studies
The predefined criteria used for the 2018 report will be used to assess … The study may be missing information,
making it difficult to assess limitations and potential problems … We will use this information to assess the situations in which the
evidence is most relevant and to